#048: Dan Freed’s $13.5M Triumph: Turning ADHD Struggles into Nootropics Success

Dan Freed, co-founder of Thesis, has emerged as a pioneering force in the wellness space by developing personalized supplements designed to enhance cognitive function. His journey is marked by overcoming early challenges, such as an ADHD diagnosis at six and dropping out of high school at sixteen. After years of working in elite kitchens, including a Michelin-three-star restaurant in France, Dan discovered his passion for brain-enhancing compounds while pursuing higher education. This led him to co-found Thesis, a company that recently secured $13.5 million in funding. In this episode, we dive into Dan’s extraordinary path from a troubled youth to a thriving entrepreneur. He reflects on the key turning points that influenced his career, including how nootropics played a crucial role in his academic and professional achievements. Dan also offers an in-depth look at the science driving Thesis, the company’s approach to personalization, and their mission to influence the future of mental wellness.